Recombinant Vaccines Market Size, Share & COVID-19 Impact Analysis, By Type (Subunit and Live Attenuated), By Route of Administration (Parenteral and Oral), By Disease Indication (Human Papillomavirus (HPV), Hepatitis B, Rotavirus, Herpes Zoster, Meningococcal B, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027

 ATTRIBUTE

  DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD billion)

Segmentation

By Type

• Subunit


• Live Attenuated

By Route of Administration

• Parenteral


• Oral

By Disease Indication

• Human Papillomavirus (HPV)


• Hepatitis B


• Rotavirus


• Herpes Zoster


• Meningococcal B


• Others

By Distribution Channel

• Hospital & Retail Pharmacies


• Government Suppliers


• Others

By Geography

• North America (U.S. and Canada)


• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)


• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)


• Latin America (Brazil, Mexico, and the Rest of Latin America)


• The Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)